Cited by 25Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatmentsHistorical and Modern Theater Studies

Diagnostic accuracy of CERAD total score in a Colombian cohort with mild cognitive impairment and Alzheimer's disease affected by E280A mutation on presenilin-1 gene

Open access
Aguirre-Acevedo, Daniel Camilo, Jaimes-Barragán, Fabian, Henao, Eliana, Tirado, Victoria, Muñoz, Claudia, Reiman, Eric M., Tariot, Pierre N., Langbaum, Jessica B. +1 more·2016·International Psychogeriatrics

Abstract

BACKGROUND: This study aimed to determine Consortium to Establish a Registry for Alzheimer's Disease (CERAD) Neuropsychological Assessment Battery total score diagnostic accuracy in the diagnosis of mild cognitive impairment (MCI) and dementia in familial Alzheimer's disease (FAD) with E280A mutation on presenilin-1 gene (PSEN1). METHODS: A cross-sectional study was conducted in a cohort of PSEN1 E280A carriers and non-carriers assessed between January 1995 and February 2013. During the first neuropsychological assessment, 76 were having dementia, 46 had MCI, and 1,576 were asymptomatic. CERAD cut-off points were established for MCI and dementia using a Receiver Operating Characteristics (ROC) analysis, and were further analyzed according to education level in two groups: low education level (eight years or less), and high education level (over eight years). RESULTS: The area under curve-ROC CERAD total score for dementia was 0.994 (95% CI = 0.989-0.999), and that for MCI was 0.862 (95% CI = 0.816-0.908). The dementia diagnosis cut-off point for the low education group was 54, (98.4% sensitivity, 92.6% specificity), and that for the high education group was 67 (100% sensitivity, 94.1% specificity). The MCI diagnosis cut-off point for the low education group was 66 (91.2% sensitivity, 56.4% specificity), and that for the high education group was 72 (91.7% sensitivity, 76.3% specificity). CONCLUSIONS: The CERAD total score is a useful screening tool for dementia and MCI in a population at risk of FAD.

Integrity signals

Registry

Crossref · 10.1017/s1041610215001660

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The neuropsychological battery had been adapted and validated to detect Alzheimer's disease-related cognitive impairment in this kindred.

    “Neuropsychological assessments were conducted in Spanish with the use of a battery that has been adapted and validated for the detection of Alzheimer’s disease–related cognitive impairment in this kindred”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Aguirre-Acevedo, D. C., Jaimes-Barragán, F., Henao, E., Tirado, V., Muñoz, C., Reiman, E. M., Tariot, P. N., Langbaum, J. B., & Lopera, F.
Affiliations
  • Universidad de Antioquia (CO)
  • Banner Alzheimer’s Institute (US)
Venue
International Psychogeriatrics
Publisher
Elsevier BV
Published
2016-03
Volume
28
Issue
3
Pages
503-510
ISSN
1041-6102 (ISSN-L)
OpenAlex
W1794166075
Cited by
25
References
26
Citations by year
2026: 4 · 2025: 3 · 2024: 2 · 2023: 2 · 2022: 1 · 2021: 3 · 2020: 4 · 2019: 2 · 2018: 2 · 2017: 1 · 2016: 1
FWCI
1.08
Type
journal article
Language
en
Open access
Locations
  • International Psychogeriatrics (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • Institutional Repository University of Antioquia (University of Antioquia) (submittedVersion, cc-by-nc-nd)
Funders
National Institute on Aging (R01AG055444)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Social Sciences › Psychology › Clinical Psychology › Historical and Modern Theater Studies
Keywords
mild cognitive impairment, dementia, familial Alzheimer's disease, PSEN1 E280A mutation, presenilin 1, diagnostic accuracy, neuropsychological assessment, educational attainment, dementia screening
MeSH terms
Aged, Aged, 80 and over, Alzheimer Disease, Amnesia, Colombia, Cross-Sectional Studies, Female, Genetic Markers, Humans, Male, Middle Aged, Mutation, Neuropsychological Tests, Sensitivity and Specificity, Severity of Illness Index, Reproducibility of Results, Area Under Curve, Genetic Predisposition to Disease, Recognition, Psychology, Presenilin-1, Cognitive Dysfunction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review